The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

被引:75
|
作者
Graff-Guerrero, Ariel [1 ,2 ,3 ]
Mizrahi, Romina [1 ,2 ]
Agid, Ofer [1 ,2 ]
Marcon, Heidi [1 ]
Barsoum, Penny [1 ]
Rusjan, Pablo [1 ]
Wilson, Alan A. [1 ,2 ]
Zipursky, Robert [2 ,4 ,5 ]
Kapur, Shitij [1 ,2 ,6 ]
机构
[1] Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Queretaro, Mexico
[4] McMaster Univ, Dept Psychiat, Hamilton, ON L8S 4L8, Canada
[5] McMaster Univ, Dept Behav Neurosci, Hamilton, ON L8S 4L8, Canada
[6] Kings Coll London, Inst Psychiat, London SE5 8AF, England
基金
加拿大健康研究院;
关键词
schizophrenia; psychosis; C-11]-(+)-PHNO; D-3; D-2; high-affinity state; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; ENDOGENOUS DOPAMINE; AGONIST RADIOLIGAND; D2(HIGH) RECEPTORS; D-2/3; AGONIST; BINDING; AMPHETAMINE; RADIOTRACER; BRAIN;
D O I
10.1038/npp.2008.199
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dopamine D-2 receptors exist in two states: a high-affinity state (D-2(high)) that is linked to second messenger systems, is responsible for functional effects, and exhibits high affinity for agonists; and a low-affinity state that is functionally inert and exhibits lower affinity for agonists. The dopamine D-3 receptors have high-affinity for agonist (eg dopamine) and the existence of the two affinity states is controversial. Although preclinical studies in animal models of psychosis have shown a selective increase of D-2(high) as the common pathway to psychosis, the D-3 has been suggested to be involved in the pathophysiology of psychosis. We report the first study of the D-2(high) and D-3 in schizophrenia using the novel PET radiotracer, [C-11]-(+)- PHNO. We recruited 13 patients with schizophrenia-spectrum disorder amidst an acute psychotic episode, drug free for at least 2 weeks, and 13 age - sex-matched healthy controls. The binding potential no-displaceable (BPND) was examine in the main regions of interest (caudate, putamen, ventral striatum, globus pallidus, substantia nigra, and anterior thalamus) and in a voxel-wise analysis. The BPND between patients and controls was not different in any of the regions. The voxel-wise analysis did not reveal any difference and no correlations were found between the BPND and positive and negative syndrome scale subscales. Our results do not find support for the hypothesis linking psychosis to a selective increase in D-2(high) and/or D-3 in schizophrenia. It is possible that receptors with high affinity are not accessible by [C-11]-(+)-PHNO because they are occupied by endogenous dopamine, a possibility that can be ruled out in future experiments.
引用
收藏
页码:1078 / 1086
页数:9
相关论文
共 50 条
  • [1] The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
    Ariel Graff-Guerrero
    Romina Mizrahi
    Ofer Agid
    Heidi Marcon
    Penny Barsoum
    Pablo Rusjan
    Alan A Wilson
    Robert Zipursky
    Shitij Kapur
    Neuropsychopharmacology, 2009, 34 : 1078 - 1086
  • [2] The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors A Positron Emission Tomography Study With [11C]-(+)-PHNO
    Graff-Guerrero, Ariel
    Mamo, David
    Shammi, C. M.
    Mizrahi, Romina
    Marcon, Heidi
    Barsoum, Penny
    Rusjan, Pablo
    Houle, Sylvain
    Wilson, Alan A.
    Kapur, Shitij
    ARCHIVES OF GENERAL PSYCHIATRY, 2009, 66 (06) : 606 - +
  • [3] Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Payer, Doris
    Di Ciano, Patricia
    Guranda, Mihail
    Nakajima, Shinichiro
    Tong, Junchao
    Mansouri, Esmaeil
    Wilson, Alan A.
    Houle, Sylvain
    Meyer, Jeff H.
    Graff-Guerrero, Ariel
    Boileau, Isabelle
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (02) : 529 - 537
  • [4] Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Bernard Le Foll
    Doris Payer
    Patricia Di Ciano
    Mihail Guranda
    Shinichiro Nakajima
    Junchao Tong
    Esmaeil Mansouri
    Alan A Wilson
    Sylvain Houle
    Jeff H Meyer
    Ariel Graff-Guerrero
    Isabelle Boileau
    Neuropsychopharmacology, 2016, 41 : 529 - 537
  • [5] Occupancy of Dopamine D2 and D3 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Payer, Doris
    Di Ciano, Patricia
    Guranda, Mihail
    Nakajima, Shinichiro
    Tong, Junchao
    Mansouri, Esmaeil
    Wilson, Alan
    Houle, Sylvain
    Meyer, Jeff
    Graff, Ariel
    Boileau, Isabelle
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 94S - 94S
  • [6] Age-Dependent Decline in Dopamine D2 Receptors but not D3 Receptors in Healthy Volunteers: A [11C]-(+)-PHNO and [11C]-Raclopride PET Study
    Graff-Guerrero, Ariel
    Shammi, C. M.
    Uchida, Hiroyuki
    Shitij, Kapur
    Mamo, David
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 9S - 9S
  • [7] High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO
    Willeit, M
    Ginovart, N
    Kapur, S
    Houle, S
    Hussey, D
    Seeman, P
    Wilson, AA
    BIOLOGICAL PSYCHIATRY, 2006, 59 (05) : 389 - 394
  • [8] In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C] PHNO
    Girgis, Ragy
    Easwaramoorthy, Balu
    Castrillon, John
    Gunn, Roger
    Rabiner, Eugenii
    Abi-Dargham, Anissa
    Slifstein, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [9] In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
    Ragy R Girgis
    Xiaoyan Xu
    Nobumi Miyake
    Balu Easwaramoorthy
    Roger N Gunn
    Eugenii A Rabiner
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2011, 36 : 887 - 895
  • [10] In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
    Girgis, Ragy R.
    Xu, Xiaoyan
    Miyake, Nobumi
    Easwaramoorthy, Balu
    Gunn, Roger N.
    Rabiner, Eugenii A.
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (04) : 887 - 895